These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 4025007)
21. Hormonal regulation of water metabolism in children with nephrotic syndrome. Rascher W; Tulassay T Kidney Int Suppl; 1987 Aug; 21():S83-9. PubMed ID: 3306110 [TBL] [Abstract][Full Text] [Related]
22. Increased atrial natriuretic peptide in the nephrotic syndrome. Relationship to the renal function and the renin-angiotensin-aldosterone system. Pedersen EB; Danielsen H; Eiskjaer H; Jespersen B; Sørensen SS Scand J Clin Lab Invest; 1988 Apr; 48(2):141-7. PubMed ID: 2965826 [TBL] [Abstract][Full Text] [Related]
23. Co-administration of albumin-furosemide in patients with the nephrotic syndrome. Ghafari A; Mehdizadeh A; Alavi-Darazam I; Rahimi E; Kargar C; Sepehrvand N Saudi J Kidney Dis Transpl; 2011 May; 22(3):471-5. PubMed ID: 21566302 [TBL] [Abstract][Full Text] [Related]
24. The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II. Düsing R; Vetter H; Kramer HJ Nephron; 1980; 25(4):187-92. PubMed ID: 6990285 [No Abstract] [Full Text] [Related]
25. Role of aldosterone in the sodium retention of patients with nephrotic syndrome. Shapiro MD; Hasbargen J; Hensen J; Schrier RW Am J Nephrol; 1990; 10(1):44-8. PubMed ID: 2188506 [TBL] [Abstract][Full Text] [Related]
26. Effect of angiotensin, noradrenaline, vasopressin and aldosterone on urinary kallikrein excretion in the rat. Catanzaro OL; Martinez Seeber A; Vila SB Pharmacol Res Commun; 1984 Aug; 16(8):775-83. PubMed ID: 6567941 [TBL] [Abstract][Full Text] [Related]
27. Sodium excretion in the nephrotic syndrome. Relation to serum albumin concentration, glomerular filtration rate, and aldosterone excretion rate. Oliver WJ; Owings CL Am J Dis Child; 1967 Mar; 113(3):352-62. PubMed ID: 6019453 [No Abstract] [Full Text] [Related]
29. Impaired renal water excretion in early hepatic cirrhosis. Lack of relationship between renal water excretion and plasma levels of arginine vasopressin, angiotensin II, and aldosterone after water loading. Madsen M; Pedersen EB; Danielsen H; Jensen LS; Sørensen SS Scand J Gastroenterol; 1986 Aug; 21(6):749-55. PubMed ID: 3749808 [TBL] [Abstract][Full Text] [Related]
30. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782 [TBL] [Abstract][Full Text] [Related]
31. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system. Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690 [TBL] [Abstract][Full Text] [Related]
32. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739 [TBL] [Abstract][Full Text] [Related]
34. Acute tolerance to furosemide. Pretreatment with captopril or prazosin does not influence diuresis and natriuresis. Kron BG; Sjöström PA; Karlberg BE; Odlind BG Scand J Urol Nephrol; 1994 Dec; 28(4):337-44. PubMed ID: 7886407 [TBL] [Abstract][Full Text] [Related]
35. Thirst and sodium appetite in rats with experimental nephrotic syndrome. Xu J; Johnson AK; Thunhorst RL Physiol Behav; 2015 Oct; 149():317-23. PubMed ID: 26120029 [TBL] [Abstract][Full Text] [Related]
36. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Sørensen SS; Danielsen H; Jespersen B; Pedersen EB Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595 [TBL] [Abstract][Full Text] [Related]
37. Studies on diurnal blood pressure variation in kidney diseases associated with excessive salt and water retention. Barenbrock M; Spieker C; Hausberg M; Rahn KH; Zidek W; Kisters K J Hum Hypertens; 1999 Apr; 13(4):269-73. PubMed ID: 10333346 [TBL] [Abstract][Full Text] [Related]
38. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Gottlieb SS; Brater DC; Thomas I; Havranek E; Bourge R; Goldman S; Dyer F; Gomez M; Bennett D; Ticho B; Beckman E; Abraham WT Circulation; 2002 Mar; 105(11):1348-53. PubMed ID: 11901047 [TBL] [Abstract][Full Text] [Related]
39. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure. Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220 [TBL] [Abstract][Full Text] [Related]
40. Renal response to AVP and DDAVP after angiotensin II blockade in the rat. Fejes-Tóth G; Zahajszky T; Filep J Am J Physiol; 1983 Feb; 244(2):F205-9. PubMed ID: 6186147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]